NCT05234866 · RECRUITING

Paradoxical Lucidity in Severe End-Stage Dementia

This study is observational, not a drug or device trial. Researchers want to understand paradoxical lucidity — those surprising moments when someone with severe, end-stage dementia suddenly seems mentally clear. The team is building a definition, a measurement scale, and looking at brainwave patterns using video EEG during these episodes. Details on phase and design are limited, but this is early foundational research, not a treatment being tested.

You may qualify if

  • Age > 18 years
  • Advanced (severe) dementia diagnosed using the Global Deterioration Scale (GDS) with a score of 7 or the Palliative Performance Scale (PPS) with a score of less than 30%
  • Accepted for hospice care based on the Medicare eligibility guidelines
  • No longer being provided with nutrition or fluids
  • Anuria (dry diaper) or less than 200cc urine (almost dry diaper) in any 24-hour period

You're excluded if

  • Cognitive or functional impairment due to a diagnosis other than dementia
  • Dementia with a GDS score \<7 (mild, moderate, moderately severe dementia). Please refer to rationale outlined for inclusion criteria 2.

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2025-08-14

View full record on ClinicalTrials.gov

All APOE4 clinical trials